Design, synthesis, and structure–activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors
- 2 March 2005
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (7) , 1895-1899
- https://doi.org/10.1016/j.bmcl.2005.02.004
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Apoptotic and Cytostatic Farnesyltransferase Inhibitors Have Distinct Pharmacology and Efficacy Profiles in Tumor ModelsCancer Research, 2004
- Crystal Structures of the Anticancer Clinical Candidates R115777 (Tipifarnib) and BMS-214662 Complexed with Protein Farnesyltransferase Suggest a Mechanism of FTI SelectivityBiochemistry, 2004
- Discovery and Structure−Activity Relationships of Imidazole-Containing Tetrahydrobenzodiazepine Inhibitors of FarnesyltransferaseJournal of Medicinal Chemistry, 1999
- THE POTENTIAL OF FARNESYLTRANSFERASE INHIBITORS AS CANCER CHEMOTHERAPEUTICSAnnual Review of Pharmacology and Toxicology, 1997
- On the use of quantum energy surfaces in the derivation of molecular force fieldsComputer Physics Communications, 1994
- Ras C-terminal processing enzymes—New drug targets?Cell, 1991
- GTP binding and growth controlCurrent Opinion in Cell Biology, 1990
- All ras proteins are polyisoprenylated but only some are palmitoylatedCell, 1989
- ras GTPase activating protein: Signal transmitter and signal terminatorCell, 1989
- ras GENESAnnual Review of Biochemistry, 1987